Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

HGF activator helps convert HGF to its active form, promoting hair growth.

Urokinase, a type of protein, helps skin cells multiply faster, especially in newborn mice.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Early intervention and patient education are crucial for managing alopecia areata.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Skin cells control immune cell placement, helping the skin respond better to challenges.

The new skin model can predict how chemicals might cause skin allergies.

Th22 cells are essential for Tβ15-induced hair growth in mice.